Cas:206265-98-7 Boc-NH-PEG7-NH2 manufacturer & supplier

We serve Chemical Name:Boc-NH-PEG7-NH2 CAS:206265-98-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Boc-NH-PEG7-NH2

Chemical Name:Boc-NH-PEG7-NH2
CAS.NO:206265-98-7
Synonyms:Boc-NH-PEG7-CH2CH2NH2;25-Amino-5,8,11,14,17,20,23-heptaoxa-2-azapentacosanoic Acid1,1-Dimethylethyl Ester
Molecular Formula:C21H44N2O9
Molecular Weight:468.58200
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:547.7ºC at 760 mmHg
Density:1.075g/cm3
Index of Refraction:1.464
PSA:128.96000
Exact Mass:468.30500
LogP:1.67720

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Boc-NH-PEG7-CH2CH2NH2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,25-Amino-5,8,11,14,17,20,23-heptaoxa-2-azapentacosanoic Acid1,1-Dimethylethyl Ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-NH-PEG7-CH2CH2NH2 Use and application,25-Amino-5,8,11,14,17,20,23-heptaoxa-2-azapentacosanoic Acid1,1-Dimethylethyl Ester technical grade,usp/ep/jp grade.


Related News: Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. Boc-NH-PEG7-NH2 manufacturer Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report. Boc-NH-PEG7-NH2 supplier Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. Boc-NH-PEG7-NH2 vendor  The StartScore model was developed by the company��s in-house supply chain experts based on actual performance data. Boc-NH-PEG7-NH2 factory Lilly spokesperson Kathryn Beiser and a Justice Department spokesperson declined to comment. Clark did not respond to a request for comment. A Covington spokesperson did not respond to a request for comment nor to a request for a copy of the firm’s report.